Xanthine oxidase inhibitors treatment or discontinuation effects on mortality: evidence of xanthine oxidase inhibitors withdrawal syndrome

Masanari Kuwabara, Michikazu Nakai, Yoko Sumita, Yoshitaka Iwanaga, Ryusuke Ae, Takahide Kodama, Ichiro Hisatome, Naoyuki Kamatani

Open source

DOI
10.3389/fphar.2023.1289386
Published
2024-01-08
Container
Frontiers in Pharmacology
Publisher
Frontiers Media SA
Open access
unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.3389/fphar.2023.1289386,
  title = {Xanthine oxidase inhibitors treatment or discontinuation effects on mortality: evidence of xanthine oxidase inhibitors withdrawal syndrome},
  author = {Masanari Kuwabara and Michikazu Nakai and Yoko Sumita and Yoshitaka Iwanaga and Ryusuke Ae and Takahide Kodama and Ichiro Hisatome and Naoyuki Kamatani},
  year = {2024},
  journal = {Frontiers in Pharmacology},
  doi = {10.3389/fphar.2023.1289386},
  url = {https://doi.org/10.3389/fphar.2023.1289386}
}

RIS

TY  - JOUR
TI  - Xanthine oxidase inhibitors treatment or discontinuation effects on mortality: evidence of xanthine oxidase inhibitors withdrawal syndrome
AU  - Masanari Kuwabara
AU  - Michikazu Nakai
AU  - Yoko Sumita
AU  - Yoshitaka Iwanaga
AU  - Ryusuke Ae
AU  - Takahide Kodama
AU  - Ichiro Hisatome
AU  - Naoyuki Kamatani
PY  - 2024
JO  - Frontiers in Pharmacology
DO  - 10.3389/fphar.2023.1289386
UR  - https://doi.org/10.3389/fphar.2023.1289386
ER  - 

APA

Kuwabara, M., Nakai, M., Sumita, Y., Iwanaga, Y., Ae, R., Kodama, T., Hisatome, I., & Kamatani, N. (2024). Xanthine oxidase inhibitors treatment or discontinuation effects on mortality: evidence of xanthine oxidase inhibitors withdrawal syndrome. Frontiers in Pharmacology. https://doi.org/10.3389/fphar.2023.1289386

Source records